Viewing Study NCT04364750


Ignite Creation Date: 2025-12-24 @ 4:59 PM
Ignite Modification Date: 2025-12-25 @ 2:40 PM
Study NCT ID: NCT04364750
Status: UNKNOWN
Last Update Posted: 2023-09-26
First Post: 2020-04-23
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Biomarkers of Diet-microbiota Interactions in Irritable Bowel Syndrome
Sponsor: McMaster University
Organization:

Study Overview

Official Title: Biomarkers of Diet-microbiota Interactions in Irritable Bowel Syndrome
Status: UNKNOWN
Status Verified Date: 2023-09
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Most patients suffering from the irritable bowel syndrome (IBS) report that ingestion of certain foods is a major trigger of symptoms, but the reason is unclear. Previous studies have shown that foods containing poorly absorbed carbohydrates (FODMAPs) are fermented by the bacteria in our bowels and these cause symptoms in some but not all patients. Gut bacteria are capable of producing various products, such as neuroimmune mediator histamine, that may be related to IBS symptoms. Our recent data suggest that consumption of FODMAPs promotes production of bacterial histamine.

The main objective of this study is to investigate bacterial production of histamine and its relationship to IBS symptoms. The study will involve 6 weeks on a low-FODMAP diet with three three-day interventions consisting of High- or Low-FODMAP drinks along with probiotics or placebo capsules. The patient's bacteria and metabolites will be analyzed at various time points.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: